RIVM - The newborn blood spot screening in the Netherlands: monitor 2021
report
The aim of the Newborn Blood Spot screening programme (NBS) is the early detection of a number of serious, rare, congenital conditions in newborns. The target disease is the variant of the disorder we want to detect with neonatal screening. The screening is designed to preferably detect all children with the target disease and no or as few as possible children with another variant (secondary finding). If these target diseases are detected early, irreversible health damage can be prevented or limited through timely treatment with, for example, medication or diet.
TNO Identifier
981500
Publisher
TNO
Collation
10 p.
Place of publication
Leiden
Files
To receive the publication files, please send an e-mail request to TNO Repository.